|Bid||274.93 x 1000|
|Ask||275.20 x 800|
|Day's Range||274.67 - 278.63|
|52 Week Range||215.78 - 374.99|
|Beta (5Y Monthly)||0.51|
|PE Ratio (TTM)||8.08|
|Earnings Date||Oct 20, 2020 - Oct 26, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||300.54|
News about a generic-drug business sent shares of Kodak all over the place. Now investors have to figure out what a new pharma business is worth. It isn’t an easy job.
Health care, one of the largest and most complex sectors, is comprised of a broad range of companies that sell medical products and services. The health care sector includes companies that sell drugs, medical devices, and insurance, as well as hospitals and health care providers. Health care stocks, as represented by the Health Care Select Sector SPDR ETF (XLV), have outperformed the broader market, providing investors with a total return of 17.0% compared to the S&P 500's total return of 9.0% over the past 12 months. Several of these companies have received U.S. Emergency Use Authorization to develop either tests or treatments for COVID-19, sharply boosting their share price.
You can also gather a much clearer picture of the strength of a stock based on how it does or doesn't perform during a global recession. If you own shares of Biogen (NASDAQ: BIIB) or are thinking about purchasing this stock, you might be curious about what your investment would look like now if you'd bought in during the 2008 recession. If you had bought $1,000 worth of Biogen back then, how much would you have today?